Rozen Law Office Announces Deadline to Join Securities Class Actions Involving ADMA, GPK, LCID and Others
Rozen Law Office has announced investor participation deadlines for multiple securities class actions against U.S. companies including ADMA Biologics, Graphic Packaging, Lucid, ChampionX and Zoetis. Because the applicable period and lead plaintiff application deadline differ for each case, investors should check the relevant holding or trading period and loss criteria.
Rozen Law Office has announced investor participation deadlines for securities class actions against several U.S.-listed companies. Investors should verify whether the time they held or purchased the securities falls within the applicable period.
The litigation involving ADMA Biologics covers investors who traded from 2024 year 8 month 9 through 2026 year 3 month 25 and is open to investors who traded through 2026 year 8 month 10. The lawsuit alleges undisclosed transactions involving related parties, channel stuffing and inadequate internal controls.
The litigation involving Graphic Packaging covers investors who traded from 2025 year 2 month 4 through 2026 year 2 month 2. Investors whose losses exceed 10 million dollars may apply to serve as lead plaintiffs by 2026 year 7 month 6. The plaintiffs allege that, due to inventory management problems, weakening demand, rising costs and exaggerated business continuity, the 2025 guidance was not reliable.
The Lucid Group lawsuit concerns investors who traded from 2026 year 2 month 25 to 2026 year 4 month 13; the lead plaintiff filing deadline is 2026 year 7 month 28. The lawsuit alleges that Gravity deliveries were delayed due to supplier quality issues and that manufacturing capabilities were exaggerated. The stated loss threshold is more than 10 ten thousand dollars.
The ChampionX lawsuit includes investors who traded from 2024 year 2 month 29 to 2024 year 4 month 1; the deadline to apply as lead plaintiff is 2026 year 7 month 14. The plaintiffs allege that the company repurchased its own shares without disclosing Schlumberger's acquisition offer, artificially lowering the share price. The loss threshold is 10 ten thousand dollars.
The lawsuit related to Zoetis was filed based on the alleged failure to disclose weakening sales of its key products, Librela and Simparica Trio, safety concerns, and intensifying competition. The deadline for the lead plaintiff in this case is 2026 year 7 month 27, and the loss threshold is 10 ten thousand dollars.
The Rosen parties are encouraging investors to seek appointment as legal representatives in each case. To decide whether to participate in the lawsuits before each deadline, investors must verify their trading records and the scale of their losses.
Sources: GlobeNewswire Inc.
Bullstory synthesized this report from the linked sources. AI may have assisted the writing process. Check the original reports for factual confirmation.